Simply Wall St has reduced its fair value estimate for QuidelOrtho from $20.50 to $12.00 per share, reflecting lower growth expectations. The revision follows a cut in the revenue growth assumption from 3.76% to 0.81% and a lower assumed future P/E multiple from 5.66x to 3.60x, while the net profit margin assumption was raised slightly to 12.13% and the discount rate increased to 12.54%. Analyst price targets now cluster between $12 and $18, with Citi lifting its target to $18 from $13 while keeping a Neutral rating, and JPMorgan setting a $12 target with an Underweight rating. The divergence highlights ongoing uncertainty about QuidelOrtho's growth path and execution risks.
Quidel CorporationFair value estimate cut to $12, reflecting lower growth expectations and execution risks.
